|
Online Database of Chemicals from Around the World | Search | Submit | Advertise |
Home >> Chemical Listing >> Zoliflodacin>> Market Analysis Reports |
Market Analysis Reports of Zoliflodacin |
|
Gonorrhea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Gonorrhea Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gonorrhea - Drugs in Development by Stages, Target, MoA, RoA ... DNA gyrase inhibitors - Pipeline Insight, 2022 ... designations for TNP-2092. Zoliflodacin: Entasis Therapeutics Zoliflodacin (ETX0914) is an orally bioavailable antibacterial ... Ocumension Therapeutics Microbiotix Key Products Zoliflodacin Finafloxacin TNP 2092 SPR 720 ... Gonorrhoea - Pipeline Insight, 2021 ... tract infection (uUTI)/gonorrhea. Zoliflodacin: Entasis Therapeutics Zoliflodacin (ETX0914) is an orally bioavailable antibacterial ... Key Products EVO 100 Gepotidacin Zoliflodacin F 598 Research programme: Enoyl-ACP ... Global Antibiotics Market - Distribution by Type of Drug Class (Aminoglycosides, Cephalosporins, Fluoroquinolones, Macrolides, Oxazolidinones, Penicillins, Sulphonamides, Tetracyclines and Other Drug Classes), Target Disease Indication (Bacterial Infections, Skin Infections, Gastrointestinal Infections, Hematological Infections, Nephrological Infections, Pulmonary Infections, Reproductive Tract Infections, Respiratory Tract Infections, Sexually Transmitted Diseases, Urinary Tract Infections and Other Bacterial Infections), Type of Therapy (Monotherapies and Combination Therapies), Route of Administration (Intravenous and Oral), Key Geographical Regions (North America, Europe, Asia-Pacific and Rest of the World), and Drug-wise Sales: Industry Trends and Global Forecasts, 2023-2035 The global antibiotics market is expected to reach USD 36 billion in 2023 anticipated to grow at a CAGR of 1.2% during the forecast period 2023-2035. Bacterial infections stand as a primary contributor to global mortality, accounting for one out of every ... Gonorrhea Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034 The 7 major gonorrhea markets reached a value of US$ 1.1 Billion in 2023. Looking forward, IMARC Group expects the 7MM to reach US$ 1.4 Billion by 2034, exhibiting a growth rate (CAGR) of 2.35% during 2024-2034. The gonorrhea market has been ... |